Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
histidine kinase
Overview
Reslit |
| Candidate |
| F483I | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| R282C | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| S9P | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| V383I | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| A243T | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| H576R | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| D274A | - | gain-of-function | Bacillus subtilis | CEF | Reslit | Candidate |
| T217K | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| I594M | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| T1182I | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| G223D | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| K337E | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| L10F | - | cell wall metabolism sensor histidine kinase WalK, single resistance variant | Staphylococcus aureus | DAPTOMYCINDaptomycin | Card DatabaseReference Gene Catalog | Confirmed |
| S221P | single resistance variant, reduced autophosphorylation status of WalK, thereby decreasing the phosphorylation and transcriptional activity of WalR, enhanced vancomycin resistance, cell wall metabolism sensor histidine kinase WalK | Staphylococcus aureus | DaptomycinVancomycinDAPTOMYCIN | Card DatabaseReference Gene CatalogReslit | Confirmed |
| R263C | - | single resistance variant, cell wall metabolism sensor histidine kinase WalK | Staphylococcus aureus | DaptomycinDAPTOMYCIN | Card DatabaseReference Gene Catalog | Confirmed |
| R123K | - | - | Staphylococcus aureus | Daptomycin | Reslit | Candidate |
| N283E | - | - | L. monocytogenes | Penicillin | Reslit | Candidate |
| Y272A | - | - | Staphylococcus epidermidis | Dalbavancin | Reslit | Candidate |
| Y505H | - | - | Staphylococcus aureus | Vancomycin|Daptomycin | Reslit | Candidate |
| R280Q | - | - | Staphylococcus haemolyticus | Vancomycin | Reslit | Candidate |
| N70K | - | - | Staphylococcus haemolyticus | Vancomycin | Reslit | Candidate |
| T357I | - | - | - | Daptomycin | Reslit | Candidate |
| M220I | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| Y225N | - | - | Staphylococcus aureus | Daptomycin | Reslit | Candidate |
| F473I | - | - | Staphylococcus aureus | Daptomycin | Reslit | Candidate |
| T492R | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| L14I | - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| A243V | - | - | Staphylococcus aureus | Cervimycin|Vancomycin | Reslit | Candidate |
| R86C | - | - | - | Methicillin | Reslit | Candidate |
| - | - | - | Daptomycin | Reslit | Candidate |
| - | - | - | Daptomycin | Reslit | Candidate |
| - | - | Staphylococcus aureus | Vancomycin | Reslit | Candidate |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| walK | Reslit | 6 | Vancomycin, Daptomycin +1 | Staphylococcus aureus +1 | Japan | 2011, 2015, 2019, 2021, 2023, 2024 | AP019542|AP019543|AP019545 | - |
| walk/R | Reslit | 1 | Vancomycin | Staphylococcus aureus +1 | - | 2021 | - | - |
walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
The study identifies walK and clpP mutations as contributing to reduced vancomycin susceptibility in Staphylococcus aureus, demonstrating that these mutations lead to increased vancomycin MIC when introduced into a susceptible strain.
Impact of daptomycin resistance on Staphylococcus aureus virulence.
IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a Staphylococcus aureus Clinical Isolate.
The study identifies mprF and dltABCD as key contributors to DAP resistance in S. aureus isolates, with a non-synonymous mutation in mprF (Trp 424 Cys) playing a significant role in increased DAP resistance.
Investigating the effect of an identified mutation within a critical site of PAS domain of WalK protein in a vancomycin-intermediate resistant Staphylococcus aureus by computational approaches.
Antibiotic resistance alters through iron-regulating Sigma factors during the interaction of Staphylococcus aureus and Pseudomonas aeruginosa.
The study shows that the interaction between S. aureus and P. aeruginosa influences antibiotic resistance through changes in the expression of genes such as kpc, mexA-mexB-oprM, oprD, norA, and walk/R, which are involved in carbapenem, ciprofloxacin, and vancomycin resistance.
Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections.
Asymmetric total synthesis of polycyclic xanthenes and discovery of a WalK activator active against MRSA.
The study describes the asymmetric total synthesis of polycyclic xanthenes and identifies compound 22 as a novel WalK activator with antibacterial activity against MRSA. Mutations in the walK gene were found to reduce susceptibility to 22.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research